MM: Miguel Martín is a medical oncologist, Professor of Medicine at the Complutense University and Head of Medical Oncology Service (Hospital General Universitario Gregorio Marañon, Madrid, Spain). He received his medical degree at the University of Valladolid and completed his fellowship and residency at the San Carlos University Hospital, Madrid. His areas of research include systemic treatment in all stages of breast cancer. Prof. Martín created GEICAM (Spanish Group for Breast Cancer Research) a network involving more than 140 Spanish institutions. Since 2001, Prof. Martín serves as a member of the Board of Directors for the Scientific Steering Committee of TRIO (Translational Research in Oncology) an international non-profit clinical research organization involving 45 different countries. Prof. Martín is the first or corresponding author of more than 200 original papers and editorials published in peer-reviewed journals. In 2006, he was appointed European Liaison of the International Affairs Committee of ASCO. He has served as a panel member for the International Consensus Conference of Early Breast Cancer (St Gallen) and is currently a member of the Steering Committee for Early Breast Cancer Trialists Cooperative Group (Oxford, UK). In 2012, Prof. Martín was nominated Advisor of the Spanish Ministry of Health, and in 2015 was named Numerary Academic of the Spanish Medical Surgery Academy.